February 19, 2014

Oral, esophageal cancers a higher risk in post-allogeneic hematopoietic stem cell transplantation patients: study

(BioNews) – New research has recently revealed there could be higher risk associated with the development of secondary solid cancers, oral cancers and esophageal cancers after receiving a treatment called allogeneic hematopoietic stem cell transplantation (allogeneic HSCT). HSCT, which involves the transplantation of … Read More



 
 

February 19, 2014

Autologous stem cell tranplant in multiple sclerosis leads to extensive renewal of the T cell repertoire

(Medical News Today) – A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. n the Immune Tolerance Network’s (ITN) HALT-MS study, … Read More